Mesut Ayer
Overview
Explore the profile of Mesut Ayer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
100
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Demir F, Caytemel C, Caf N, Turkoglu Z, Ayer M, Buyukbabani N
Indian J Dermatol
. 2022 Jan;
66(5):574.
PMID: 35068533
Olmsted syndrome is a rare genodermatosis. Palmoplantar keratoderma and periorificial keratodermic plaques are the most important clinical findings. Additional findings associated with a large number of systems may accompany such...
12.
Bulbul H, Irak K, Berk S, Ulusoy Y, Ayer M
Gastroenterol Nurs
. 2022 Jan;
45(1):63-66.
PMID: 35020633
No abstract available.
13.
Keklik Karadag F, Yenerel M, Yilmaz M, Uskudar H, Ozkocaman V, Firatli Tuglular T, et al.
Am J Blood Res
. 2021 Jul;
11(3):279-285.
PMID: 34322292
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare X-linked genetic disorder. On the contrary to its name, it is a multisystemic disease and various symptoms other than hemoglobinuria could be occurred....
14.
Sarici A, Ar M, Yokus O, Ongoren S, Ayer M, Altindal S, et al.
Transfus Apher Sci
. 2020 Jun;
59(5):102845.
PMID: 32591291
Purpose: Early comorbidity detection has been reported to be associated with treatment-related outcomes in several diseases. Two main goals of the present study were to investigate both the impact of...
15.
Cekdemir D, Guvenc S, Ozdemirkiran F, Eser A, Toptas T, Ozkocaman V, et al.
Turk J Haematol
. 2019 Jul;
36(4):230-237.
PMID: 31327186
Objective: The aim of the present study was to evaluate the efficacy and safety of eltrombopag, an oral thrombopoietin receptor agonist, in patients with chronic immune thrombocytopenia (ITP). Materials And...
16.
Sengul Samanci N, Ayer M
Indian J Med Res
. 2019 May;
149(1):78-79.
PMID: 31115382
No abstract available.
17.
Cetin G, Dogan E, Sengul Samanci N, Ayer M, Ozkan T, Ekinci I, et al.
J Oncol Pharm Pract
. 2019 Mar;
26(1):99-104.
PMID: 30924740
Objective: This study was conducted with the aim of making the contribution to a decision for treatment and determination of the modalities in patients diagnosed with non-Hodgkın lymphoma which increasingly...
18.
Sariman M, Abaci N, Ekmekci S, Cakiris A, Percin Pacal F, Ustek D, et al.
Balkan Med J
. 2018 Aug;
36(1):23-31.
PMID: 30079703
Background: Multiple myeloma is a plasma cell dyscrasia characterized by transformation of B cells into malignant cells. Although there are data regarding the molecular pathology of multiple myeloma, the molecular...
19.
Ustaoglu M, Onder F, Solmaz N, Ozturk S, Ayer M
Turk J Ophthalmol
. 2018 Jan;
47(6):348-350.
PMID: 29326853
A 25-year-old woman presented with acute bilateral blurred vision and history of headache, dizziness, and syncope for three days. Her visual acuity was 20/60 in both eyes. Fundoscopy revealed multiple...
20.
Eskazan A, Sadri S, Keskin D, Ayer M, Kantarcioglu B, Demirel N, et al.
Clin Lymphoma Myeloma Leuk
. 2017 Aug;
17(12):804-811.
PMID: 28847475
Background: The molecular response at 3 months of the original imatinib (OI) in patients with chronic myeloid leukemia has prognostic significance; however, this has never been tested for generic imatinib...